![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Food Research and Development Centre, Agriculture and Agri-Food Canada, Saint Hyacinthe, QC, Canada
* To whom correspondence should be addressed. E-mail: farnworthed{at}agr.gc.ca.
As the health benefits of ingesting live bacteria become more evident, foods are now being produced that contain probiotic bacteria. The data to support label health claims for probiotic products are often difficult to provide. The experimental evidence to identify probiotic microorganisms and to demonstrate their efficacy in clinical trials is more challenging than for other potential functional foods because effects are mediated by living microorganisms and may therefore be influenced by the status of these microorganisms. Clinical trials to show efficacy are expensive. Obtaining appropriate samples is difficult. A scientific consensus is building to support the claim that the ingestion of certain probiotic bacteria reduces lactose intolerance and can reduce the duration of rotavirus diarrheas. Some probiotic bacteria have "generally accepted as safe" status; proof of the safety of any probiotic is essential. Japanese health regulatory officials, using their Foods for Specific Health Use system, have approved human health claims for over 20 probiotic products. On the other hand, at this time, no probiotic product is sold in Canada that carries a label health claim. This illustrates the considerable discrepancies across countries in perception of health effects of probiotics.
This article has been cited by other articles:
![]() |
P. J. H. Jones, N.-G. Asp, and P. Silva Proceedings of a symposium held at the Canadian Nutrition Congress. June 21, 2007. Winnipeg, Canada. J. Nutr., June 1, 2008; 138(6): 1189S - 1260S. [Full Text] [PDF] |
||||
![]() |
K. Yamada, N. Sato-Mito, J. Nagata, and K. Umegaki Health Claim Evidence Requirements in Japan J. Nutr., June 1, 2008; 138(6): 1192S - 1198S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang Scientific Substantiation of Functional Food Health Claims in China J. Nutr., June 1, 2008; 138(6): 1199S - 1205S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Tapsell Evidence for Health Claims: A Perspective from the Australia-New Zealand Region J. Nutr., June 1, 2008; 138(6): 1206S - 1209S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-G. Asp and S. Bryngelsson Health Claims in Europe: New Legislation and PASSCLAIM for Substantiation J. Nutr., June 1, 2008; 138(6): 1210S - 1215S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Hasler Health Claims in the United States: An Aid to the Public or a Source of Confusion? J. Nutr., June 1, 2008; 138(6): 1216S - 1220S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. L'Abbe, L. Dumais, E. Chao, and B. Junkins Health Claims on Foods in Canada J. Nutr., June 1, 2008; 138(6): 1221S - 1227S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jew, C. A. Vanstone, J.-M. Antoine, and P. J. H. Jones Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions J. Nutr., June 1, 2008; 138(6): 1228S - 1236S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Ames and C. R. Rhymer Issues Surrounding Health Claims for Barley J. Nutr., June 1, 2008; 138(6): 1237S - 1243S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Xiao Health Effects of Soy Protein and Isoflavones in Humans J. Nutr., June 1, 2008; 138(6): 1244S - 1249S. [Abstract] [Full Text] [PDF] |
||||